Brewers Outright Alec Bettinger

The Brewers announced that right-hander Alec Bettinger has cleared waivers and been sent outright to Triple-A Nashville. There’d be no prior indication he’d been designated for assignment, so the move clears a spot on the 40-man roster. That tally now sits at 37.

Bettinger, 26, has four MLB appearances under his belt. Those all came last season, when he worked ten innings of 15-run ball. That obviously wasn’t the way Bettinger wanted to start his career, as he surrendered a trio of home runs while walking three and striking out five. He had a more solid showing over a larger body of work in Nashville, however. Over 96 2/3 frames in a hitter-friendly environment, the University of Virginia product posted a 4.75 ERA with a solid 23.6% strikeout rate and a 6.3% walk percentage.

This season, Bettinger has made a pair of appearances for the Sounds. He tossed five innings of four-run ball before losing his roster spot, which he’ll now try to reclaim. It’s the first career outright for Bettinger, so he doesn’t have the right to refuse a minor league assignment. He’ll remain with the organization and look to pitch his way back to the majors.

Cubs Reinstate Marcus Stroman

The Cubs announced they’ve activated Marcus Stroman from the COVID-19 injured list. He’ll take the ball tonight against the Diamondbacks, with righty Michael Rucker landing on the 15-day injured list because of turf toe. Stroman hadn’t counted against the 40-man roster while on the COVID IL, and the Cubs freed a spot for his reinstatement by transferring starter Alec Mills from the 15-day to the 60-day IL.

Stroman signed a three-year, $71MM guarantee as part of an aggressive Cubs offseason. He has made five starts with his new team, tossing 26 1/3 innings of 5.13 ERA ball. Stroman’s typically excellent ground-ball rate is down to a more ordinary 45.6% in the early going, but that’s likely not much more than a sample blip. The 31-year-old’s velocity, strikeout and walk numbers are all in line with their 2021 marks, although he’s also seen a dip in swinging strikes.

In any event, Stroman returns to again take the ball every fifth day from skipper David Ross. He’ll be joined in the rotation by Kyle Hendricks, offseason signee Drew SmylyWade Miley and Justin Steele. That group looked like a concern heading into the season, and the Cubs rank among the league’s bottom ten in rotation ERA (4.45) and strikeout rate (18.5%), although they’ve been a top ten group at generating grounders (46.1%).

Mills was a significant member of the rotation last season, starting 20 of his 32 appearances. He posted a 5.07 ERA but threw strikes and induced grounders on over half the batted balls against him, setting him up as a back-of-the-rotation option. He opened the season on the injured list with a low back strain, and he’s also battled a quad issue.

Today’s transfer is largely a procedural move, as it rules Mills out for 60 days from Opening Day, not today. He can’t return to the big leagues until the first week of June, which didn’t seem likely anyways considering he’s yet to start a minor league rehab assignment. Mills recently threw a live batting practice session, however, the opening stages of a new ramp-up program.

Rangers Option Nick Solak, Release Matt Carpenter

The Rangers announced this afternoon that catcher Mitch Garver is returning from the 10-day injured list. To open space on the active roster, corner outfielder Nick Solak has been optioned to Triple-A Round Rock. Texas also announced that veteran infielder Matt Carpenter has been released from his minor league contract, making him a free agent.

Garver returns after a minimal IL stint because of a muscle strain in his forearm. Texas acquired the power-hitting backstop in a key offseason deal with the Twins, and he’s thus far appeared in 22 games with his new team. Garver is off to a relatively slow start, hitting .205/.292/.346 with a trio of homers in 89 trips to the plate. Backup catcher Jonah Heim has been excellent all season, though, and he and Garver figure to share a fair bit of time behind the dish and at designated hitter.

Solak is a former second-round pick and highly-regarded prospect. Texas acquired him from the Rays in July 2019 for reliever Pete Fairbanks, hoping they’d landed their long-term second baseman. The right-handed hitter had put up excellent numbers in the Yankees and Rays farm systems before the deal, which continued down the stretch at Texas’ top affiliate. Solak made his MLB debut late that season and hit .293/.393/.491 through his first 33 games, a continuation of the offensive upside he’d shown in the minors.

Unfortunately, he hasn’t managed to build off that early success. Solak didn’t hit for much power during the shortened 2020 season, and he stumbled to a .242/.314/.362 line over a personal-high 511 plate appearances last year. He also rated poorly defensively at the keystone, echoing concerns about his glovework that have persisted since his days as a prospect. After Texas signed a new double-play tandem of Corey Seager and Marcus Semien, they bumped Solak off the dirt entirely. He’s played exclusively left field and designated hitter to this point in 2022.

Falling further down the defensive spectrum only raises the pressure on the 27-year-old to hit. He got off to a strong start this year, primarily on the short side of a platoon. He hasn’t performed in May, however, and Texas will now send him back to the minors for more regular run. Through his first 75 plate appearances (more than half of which have come against left-handed pitching), Solak owns a .209/.293/.313 line.

Depending on how long he’s in the minors, the optional assignment could have an impact on Solak’s service trajectory. He’s on pace to hit free agency after the 2025 season, having entered the season with two years and 28 days of service time. Spending more than a month in the minors would jeopardize his ability to reach the three-year threshold after this season, although Solak will eventually need to perform better for the Rangers to tender him contracts throughout his arbitration years anyhow. With a .253/.327/.372 career line and currently squeezed off the active roster, Solak may find himself as a change-of-scenery candidate over the next couple months.

Carpenter, meanwhile, signed a non-roster deal during Spring Training. It marked a homecoming for the former TCU star, who had previously spent his entire career with the Cardinals. A three-time All-Star and two-time top ten finisher in MVP balloting in St. Louis, Carpenter saw his production turn sharply downwards by 2019. He had significant struggles in both 2020-21 and didn’t land an MLB roster spot after the Cards bought him out last fall.

The 36-year-old spoke over the offseason about the necessity to overhaul his hitting mechanics to rediscover his production at the plate. The early results have been encouraging, as Carpenter hit .275/.379/.613 and popped six homers in 21 games for Round Rock. Texas didn’t feel they had big league at-bats to offer, however, and the sides mutually agreed to part ways, relays Levi Weaver of the Athletic. It stands to reason there’ll be other teams willing to offer Carpenter a new minor league deal after his strong start for the Express.

Braves Win Arbitration Hearing Against Luke Jackson

The Braves have won their arbitration hearing against right-hander Luke Jackson, reports Mark Feinsand of MLB.com (Twitter link). He’ll be paid at the $3.6MM rate submitted by the team, as opposed to the $4MM rate filed by Jackson and his representatives.

Jackson won’t pitch this season after undergoing Tommy John surgery last month, although that factor shouldn’t have impacted his hearing outcome. Arbitration panels evaluate the cases of the team and player based on prior seasons’ performance. Hearings are typically conducted in early to mid-February, if necessary, but the 99-day lockout this offseason got in the way of arbitration proceedings and forced teams and players into the uncomfortable situation of resolving discrepancies of this nature while games are being played.

The 30-year-old Jackson has had a roller-coaster career with the Braves but enjoyed perhaps his finest season in 2021, pitching 63 2/3 innings of 1.98 ERA ball and piling up 31 holds as the team’s primary setup man. He fanned 26.8% of his opponents with a strong 52.5% grounder rate, both of which helped to offset an unpalatable 11.1% walk rate. Jackson struggled considerably in 2020 but otherwise has ranged from a serviceable to high-quality bullpen piece, evidenced by a combined 3.93 ERA in 254 innings from 2017-21.

Unfortunately for Jackson, he won’t have the chance to bolster his earning power with a repeat of last year’s performance. It’s particularly poor timing — not that there’s “good” timing for a major injury and surgery — given that Jackson has five-plus years of Major League service and is slated to become a free agent for the first time following the 2022 season. He could still garner interest on a Major League deal, especially since his surgery was performed so early in the season, but the type of multi-year deal he might’ve commanded upon replicating his 2021 output is no longer feasible.

The Braves have now won hearings over two of their arbitration-eligible players, as they also topped Austin Riley in a hearing last week. They still have unresolved cases against lefty Max Fried ($6.6MM vs. $6.85MM), shortstop Dansby Swanson ($9.2MM vs. $10MM) and outfielder Adam Duvall ($9.275MM vs. $10.275MM).

Max Scherzer Likely Out Six To Eight Weeks Due To Oblique Strain

The results of Max Scherzer‘s MRI are in, and the news isn’t great for the Mets. The team announced Thursday that Scherzer has suffered a “moderate to high grade internal oblique strain” and is expected to miss six to eight weeks. He’ll be placed on the injured list alongside co-ace Jacob deGrom (stress reaction in his scapula) and right-hander Tylor Megill (biceps inflammation).

It’s a brutal blow for the Mets, who sit at 25-14 and currently hold a six-game lead over the second-place Phillies in the National League East. Scherzer sustained the injury last night when throwing a slider to Albert Pujols, telling reporters after the game that he’d been experienced some tightness before feeling a “zing” down his side on the final pitch to Pujols. The three-time Cy Young winner immediately called for the training staff and could be seen plainly stating, “I’m done” when the staff reached the mound.

The Mets shattered precedent to get Scherzer into Queens, signing the 37-year-old righty to a three-year deal worth $130MM and giving him the highest annual salary in baseball history in doing so ($43.33MM). Owner Steve Cohen and first-year general manager Billy Eppler surely had visions of the game’s most formidable one-two punch at the time, dreaming of a playoff rotation fronted by Scherzer and deGrom.

It’s possible that duo could yet lead the Mets’ staff in the postseason, but deGrom hasn’t pitched yet in 2022 thanks to that shoulder injury. The team announced earlier this week that his latest MRI revealed “continued healing” but did not provide a timetable for his return. It’s now possible that the Mets won’t have that vaunted duo healthy and on the same roster until after the All-Star break, depending on Scherzer’s recovery.

Even in the absence of Scherzer, deGrom and Megill — whose injury should be downplayed, given the strength of his early performance — the Mets still have a solid starting staff on paper. Chris Bassitt and Carlos Carrasco have been outstanding early in the season, and the Mets have gotten quality work from Taijuan Walker and (in more limited opportunities) lefty David Peterson, too. It’s likely that Williams and Peterson will be the choices to follow the trio of Bassitt, Carrasco and Walker while the Mets navigate this latest batch of injuries.

While that’s a solid group, it obviously pales in comparison to a full-strength contingent of Mets starters. And, more concerning, the depth beyond the current quintet begins to look more questionable. Veteran left-hander Mike Montgomery is pitching with the Mets’ Triple-A affiliate but has been tagged for a 5.52 ERA through seven starts. Twenty-five-year-old Thomas Szapucki has been sharp through six Triple-A starts but has totaled just 21 innings in those outings. Righty Jordan Yamamoto has been a depth option for the Mets in the past, but he was removed from the 40-man roster earlier this season and only just made his minor league debut — 1 2/3 shaky innings in High-A — after missing time on the minor league injured list. Former Angels righty Felix Pena was brought in on a minor league deal, but like Montgomery, he’s struggled in Triple-A.

Given the manner in which injuries have already cut into the team’s depth, it wouldn’t be a surprise to see the Mets poke around the market for some depth options. Major trades this time of year are uncommon but not unheard of. Otherwise, the Mets could turn to some recently DFA’ed arms (e.g. Jharel Cotton) or veterans who’ve recently opted for minor league free agency (e.g. Drew Hutchison, Carlos Martinez) in an effort to at least stockpile some experienced options in the upper minors.

Avila: Manning Exit Not Due To Injury

12:54pm: Tigers fans can breathe a sigh of relief, it seems. General manager Al Avila tells reporters that Manning was lifted not because of an arm or shoulder injury but because he’d become increasingly light-headed and was not feeling well (Twitter link via Evan Petzold of the Detroit Free Press). It’s not yet clear whether Manning will require an additional rehab appearance due to the fact that today’s was cut short.

11:46am: Tigers righty Matt Manning exited his minor league rehab assignment in the third inning with an apparent injury, tweets Jason Beck of MLB.com. The 24-year-old landed on the injured list due to shoulder inflammation back on April 20 and was making his third start of his minor league rehab stint. Manning, who’d already walked three through his first 2 1/3 frames, plunked Pirates shortstop Kevin Newman before a visit from the trainer that ended with his departure from the game.

There’s no formal word from the Tigers just yet, but further injury for Manning will only add to what’s been a snakebitten rotation in Detroit this year. The Tigers currently have Manning, Casey Mize, Tyler Alexander, Michael Pineda and Spencer Turnbull on the injured list. Turnbull was expected to miss the bulk of the 2022 season after undergoing Tommy John surgery last summer, but the other four are dealing with 2022 injuries — and they could soon be joined by free-agent signee Eduardo Rodriguez, who left yesterday’s start against the Rays in the first inning due to an injury to his left side. Manager AJ Hinch said yesterday that Rodriguez would likely require a trip to the injured list.

Manning was the ninth overall pick in the 2016 draft and, for years, has been viewed as a potential building block on the Tigers’ pitching staff. He was hit hard through 85 1/3 innings during his MLB debut last year, although the majority of his outings were solid in nature. Manning was blown up for six or more runs in four of his 18 starts en route to a 5.80 ERA, but he finished the year with a more palatable 4.43 ERA in his final five outings. He pitched to a 2.25 ERA with four strikeouts, no walks and a 52% grounder rate in eight innings this season but left his second start after two innings due to shoulder discomfort.

The Detroit rotation is in shambles at the moment, though lefty Tarik Skubal appears to be in the midst of a bona fide breakout. He’s being followed by former first-rounder Alex Faedo and rookie Beau Brieske, and it’s not clear just where the Tigers will turn beyond that trio. Long reliever Rony Garcia impressed in relief of Rodriguez yesterday, and the Tigers also have veteran Wily Peralta in a long relief role at the moment. Peralta was a valuable pickup for them last year, making 18 starts and pitching to a 3.07 ERA — albeit with shakier underlying numbers. Down in Triple-A, veteran Chase Anderson has pitched fairly well on a minor league deal, as have 24-year-old hurlers Joey Wentz and Elvin Rodriguez — both of whom are on the 40-man roster.

Offseason In Review: Philadelphia Phillies

The Phillies missed the playoffs for the tenth straight year in 2021. That hasn’t been for a lack of aggressiveness, however, and they continued to load up for another shot at snapping the drought this past offseason. Philadelphia added two more big bats to a lineup already full of stars, hoping to overcome deficiencies elsewhere on the roster with an elite run-scoring unit.

Major League Signings

2022 spending: $64.15MM
Total spending: $204.15MM

Option Decisions

Trades and Claims

Notable Minor League Signees

Notable Losses

The story for the Phillies in 2021 was much the same as it had been in prior seasons. Few teams could match the top-end talent, with Bryce Harper posting an MVP campaign and Zack Wheeler narrowly missing out on the Cy Young. The starting rotation was excellent and the team’s top position players more or less met expectations. Yet the core couldn’t entirely compensate for a weak bottom of the lineup, a below-average defense and a bullpen that stubbornly persisted among the league’s worst. The result: an 82-win season, narrowly the franchise’s best mark in a decade but in line with the average results they posted each year from 2018-20.

Failing to earn a playoff spot with this kind of core is deflating, but a top-heavy roster of this ilk is easier to address. After all, it wasn’t hard for Phils’ brass to identify the flaws. President of baseball operations Dave Dombrowski was forthright about the team’s weaknesses at the start of the offseason. The club wasn’t committed to keeping Didi Gregorius as the primary shortstop after he struggled in the first season of a two-year deal; addressing the bullpen and outfield were priorities.

Dombrowski’s comments on Gregorius seemed to position the Phils as a viable suitor for any of the star free agent shortstops available. He name-checked top prospect Bryson Stott as a viable internal alternative, and the club’s behavior made clear that expressed faith in the 24-year-old was not mere lip service. The Phils were never closely tied to anyone of the Carlos CorreaJavier BáezCorey Seager ilk (at least publicly), and Stott would eventually make the Opening Day roster as Gregorius’ primary competition.

Philadelphia did strike more aggressively in the other areas Dombrowski cited as targets. After buying out both Odúbel Herrera and Andrew McCutchen, they were left with two outfield vacancies alongside Harper. The Phils were linked to Starling Marte in free agency and a potential Kevin Kiermaier trade but ultimately came up empty in their pursuit of a center fielder. Just before the lockout, though, the Phils made a push for Kyle Schwarber to play left field.

A deal didn’t come together before the work stoppage, but the talks set the stage for renewed discussions a few months later. In March, the Phils and Schwarber agreed to terms on a four-year, $79MM deal. The burly left-handed hitter had struggled during the 2020 season with the Cubs, leading to an eventual non-tender. After signing on with the Nationals, Schwarber turned a corner in May and broke out as the hottest hitter on the planet by June. That continued even after an injured list stint for a hamstring strain and intervening trade to the Red Sox, with the 29-year-old looking like the kind of impact bat many have envisioned since he was selected fourth overall in the 2014 draft.

The Phillies clearly believe that’s what they’re getting, and Schwarber should be a marked upgrade over late-career McCutchen. His early tenure in Philadelphia hasn’t been great, but it’s far too soon to suggest his 2021 production was a fluke. Bringing in a bat-first player like Schwarber raised a few eyebrows, given the Phils’ longstanding defensive issues, but it was a rather straightforward pickup of one of the best players available at a position of clear need.

More surprising was how the Phillies followed up on that signing. The day after they agreed to terms with Schwarber, Philadelphia was reported to be making a strong run at Nick Castellanos. A few hours later, the Phils and Castellanos came to terms on a five-year, $100MM contract. One of 13 nine-figure deals handed out over the winter, the Castellanos signing also cost the Phils a draft choice after he’d rejected a qualifying offer from the Reds.

Castellanos is a similar player as Schwarber. A middle-of-the-lineup masher, he generates huge exit velocities and power production and consistently posts excellent numbers at the dish. Castellanos’ track record is a bit more consistent and he makes a higher rate of contact — Schwarber is more dependent on drawing walks to keep his on-base percentage up — but they’re each bat-first players with bottom-tier defensive metrics in the corner outfield.

With Harper already in tow, few would’ve envisioned the Phillies landing two of the top corner outfielders available. The implementation of the universal designated hitter does afford room in the lineup for all three players. The Phils aren’t leaving manager Joe Girardi much flexibility to rotate anyone else through the DH spot — and Harper’s been a full-time DH of late after suffering a small tear in the UCL of his throwing elbow — but the Phils have thrown defense to the wind in efforts to create an elite run-scoring group.

That’s a decision that came with its share of detractors, but it’s not without logic. Adding at least one corner outfielder opposite Harper was a necessity. Also bolstering center field would’ve been more straightforward, but the alternatives there were limited. Starling Marte was the only regular available in free agency. Players like Kevin KiermaierBryan Reynolds, Cedric Mullins and even Joey Gallo were floated as possible trade candidates, but none of that group wound up changing hands. Faced with that dearth of center field options, the Phils pivoted to bringing in position player talent where opportunities presented themselves.

Would they have been better off instead signing Marte, whose deal was a near-match for Schwarber’s, alongside Castellanos? One could make that case. Yet the club was seemingly more content with the longer-term projection for Schwarber, who is four years younger than Marte with a game much less reliant on athleticism. Time will tell whether they should’ve more aggressively tried to keep the latter from the division-rival Mets, but there’s no denying the Phillies markedly improved the lineup.

That’s also true of the bullpen, where the club devoted essentially all of its remaining resources. The Phils avoided any long-term commitments there but promised a decent chunk of the 2022 payroll to typically-reliable veterans in an effort to raise the floor in the middle innings. Philadelphia landed Corey Knebel for one year and $10MM, a solid price point after the righty bounced back with a 2.45 ERA and a 29.7% strikeout rate over 27 outings for the Dodgers last season. Knebel’s 2019-20 campaigns were mostly wiped away by Tommy John surgery, and he lost a couple months to a lat injury in 2021. There are obvious durability concerns, but Knebel’s been a solidly above-average reliever when healthy since his 2017 breakout with the Brewers.

The Phils’ other bullpen pickups were more “buy low” dice rolls on formerly elite late-inning arms. Brad Hand and Jeurys Familia inked matching $6MM guarantees during Spring Training. Each was among the best relievers in the game a few years ago, but they’ve both taken steps back as they’ve entered their 30s. Hand’s velocity and swing-and-miss rate have fluctuated over the past couple seasons; Familia’s arm strength and whiffs have remained strong, but he’s been prone to bouts of wildness and occasional home run issues.

The pickups of Hand and Familia were generally reminiscent of last winter’s shot on Archie Bradley. The team has continuously shied away from longer-term commitments to relievers, seemingly averse to the volatility that plagues many late-inning arms. Attacking the bullpen with bulk lower-leverage types hasn’t worked for the Phils in years past, but it’s also hard to blame the organization for spreading their resources around. They lost Bradley, Héctor Neris and midseason trade acquisition Ian Kennedy to free agency, leaving multiple bullpen spots to plug.

Among returning relievers with 20-plus innings, only Connor Brogdon posted an ERA south of 4.00 last season. Bailey Falter and the currently-injured Sam Coonrod were the only two arms with respectable strikeout and walk numbers. José Alvarado and Seranthony Dominguez are the other holdovers, joining the free agent trio of Knebel, Hand and Familia as Girardi’s most trusted arms in high-leverage spots. A trio of smaller offseason acquisitions — trade pickups Nick Nelson and James Norwood, and minor league signee Andrew Bellatti — round out the middle innings.

While the Phillies almost completely revamped last season’s bullpen, they left the starting rotation entirely unaffected. Wheeler, Aaron Nola, 2021 breakout Ranger Suárez, midseason trade pickup Kyle Gibson, and Zach Eflin are all back as the starting five. The early results have been just alright, but that’s one of the strongest on-paper groups in the majors. The Phillies probably could’ve done more to add some depth, given how thin the rotation mix is beyond that top five, but they’re clearly confident in the primary group to stay healthy and assume the bulk of the innings throughout the summer.

Castellanos and Schwarber proved the major additions on the position player side, with the rest of the unit largely status quo. J.T. Realmuto is one of the game’s best catchers. The Phils made small moves from a depth perspective, waiving Andrew Knapp and acquiring Garrett Stubbs from the Astros and Donny Sands from the Yankees. Realmuto will play as much as any backstop around the league so long as he’s healthy.

The infield consists of holdovers Rhys HoskinsJean SeguraAlec Bohm and the aforementioned Stott/Gregorius tandem at shortstop. The Phils added former Brave Johan Camargo on a cheap one-year pact as utility depth, essentially replacing Ronald Torreyes in that role. Camargo has earned some early playing time with a respectable start. He’s a good defender at third base, offering Girardi a possible late-game alternative there to the bat-first Bohm, and he can cover the middle infield as needed.

Aside from shortstop, the one position the Phillies identified as a target area but didn’t meaningfully address wound up being center field. After missing on Marte and their trade targets, the club circled back to Herrera on a significantly cheaper deal than the $9MM option decision they’d passed up to open the winter.

The switch-hitting Herrera was fine but not great as the primary center fielder last season, and the options behind him aren’t certain. Mickey Moniak is on the injured list, Matt Vierling has an unspectacular minor league track record, and Simón Muzziotti has barely played above High-A. Roman Quinn was cut loose at the end of last season but brought back after failing to crack the Marlins’ roster out of Spring Training. He has returned to the majors as a defensive specialist and pinch-running option.

The Phillies nevertheless dealt away from their center field group, having soured on former eighth overall pick Adam Haseley. The former University of Virginia star has never hit much in the majors, and he didn’t perform well in Triple-A last season. The Phils dealt him to the White Sox for minor league reliever McKinley Moore, a move that was no doubt easier to swallow since Haseley had been drafted by the previous front office regime.

Time will tell whether the Phillies did enough to finally put forth a better than average on-field product. The early results don’t jump off the page; they’ve started 18-19, albeit with a +18 run differential. They enter play Thursday in second place in the NL East, six games back of the hot-starting Mets.

Anything short of a Wild Card berth would count as a failure. The organization has continued to aggressively add from the outside, and this latest spending spree took them into new territory financially. Signing Castellanos pushed the Phils’ season-opening payroll to around $229MM, shattering last year’s franchise record of approximately $191MM. For the first time in franchise history, owner John Middleton is likely to pay a luxury tax penalty, as the club’s estimated $236MM+ CBT hit is more than $6MM north of the $230MM base threshold. The fee for moderately exceeding the base threshold for the first time is marginal in the context of the team’s overall spending — roughly $1.2MM, pending future acquisitions — but it’s nevertheless a notable symbolic marker for the organization to cross.

That win-now mentality is unlikely to stop, and the Phillies figure to be aggressive around the trade deadline if they’re in contention as expected. Philadelphia’s farm system is generally regarded as one of the league’s worst, but no organization is entirely devoid of minor league talent. The Phils struck to acquire Gibson and Kennedy from the Rangers at last summer’s deadline. Dombrowski, general manager Sam Fuld and their staff will be equally eager to add this time around — with the bullpen, center field and perhaps back end of the rotation standing out as potential needs.

With more than ten years in the rearview mirror since the last playoff appearance, the Phillies are feeling as much pressure as any team in baseball to show results. Missing the postseason again would raise plenty of questions about the franchise’s outlook — with particular scrutiny likely to mount about Girardi, who’s in the final guaranteed season of a three-year contract. There’s enough talent here to expect to compete, but overarching concerns about the bullpen, defense and roster depth will persist until they start winning consistently.

Mariners Return Roenis Elias To Triple-A

May 19: The Mariners announced that Elias has been returned to Triple-A Tacoma. That he wasn’t passed through waivers indicates that he was indeed treated as a Covid substitute player, despite the fact that the team did not originally specify him as one. He’ll remain with the organization but won’t occupy a spot on the 40-man roster. Steckenrider, meanwhile, has been reinstated from the restricted list.

May 16: The Mariners have selected the contract of left-hander Roenis Elias from Triple-A Tacoma, per a team announcement. Right-hander Drew Steckenrider, meanwhile, has been placed on the restricted list in advance of their forthcoming three-game series against the Blue Jays in Toronto. Steckenrider is temporarily removed from the 40-man roster while on the restricted list, so the Mariners didn’t need to make an additional move to accommodate the return of Elias, who pitched with Seattle from 2014-15 and 2018-19.

Elias, 33, returned to the Mariners in hopes of a third stint when he signed a minor league deal prior to the 2021 season. He tore his left elbow’s ulnar collateral ligament during Spring Training 2021, however, and missed the entire season after the subsequent Tommy John surgery. He’s healthy again, having pitched 14 2/3 innings of 4.30 ERA ball with an 11-to-4 K/BB ratio in Triple-A Tacoma so far in 2022.

Elias has spent parts of four previous seasons with the Mariners, and while he’s also pitched with the Red Sox and Nationals, he’s never found much success outside Seattle. In 377 career innings as a Mariner, the Cuban-born southpaw has a 3.75 ERA, 14 saves and a shutout (during his 2014 run as a starter). He’s logged a combined 11 innings between Boston and Washington, surrendering 15 runs in those brief stints.

It could be a short stay on the roster for Elias, although it’s worth noting that the Mariners did not classify him as a Covid-related “substitute” player. Rather, Seattle made formal announcement of his selection to the 40-man roster. Team-by-team terminology tends to vary with respect to Covid substitutes, but the implication in this instance certainly seems to be that there’s some degree of permanence to this move. If that’s indeed the case, Elias can’t be sent back to Triple-A unless he first passes through outright waivers unclaimed. Even then, he’d have the requisite service time to reject an outright assignment to a minor league affiliate, should he choose.

As for Steckenrider, he’ll be away from the team for this three-game set and presumably rejoin them Thursday when they continue the current road trip in Boston. Travel regulations in Canada prevent unvaccinated athletes from entering the country to compete against Canadian-based teams.

Steckenrider, 31, was a revelation for the Mariners last year after signing a minor league deal. In 67 innings, he pitched to a flat 2.00 ERA with 14 saves, seven holds, a 21.7% strikeout rate and a 6.4% walk rate. It looked to be the start of an impressive rebound for Steckenrider, who shined as a setup man with the Marlins early in his career before injuries derailed his 2019-20 seasons. However, he’s stumbled again in 2022, limping to a 4.85 ERA with diminished strikeout and walk rates (15% and 8.3%, respectively). To Steckenrider’s credit, he’s been dogged by a bloated .356 average on balls in play, but even if one were to chalk some of his struggles up to that woeful BABIP, the sharp downturn in his K-BB% is nevertheless a concern. He’s being paid a $3.1MM salary this season and can be controlled through 2023 via arbitration.

Max Scherzer Undergoes MRI Following Last Night’s Early Exit

11:40am: Scherzer indeed sustained an oblique injury, tweets Jon Heyman of the New York Post. The severity of the injury isn’t yet known, although as Heyman points out, even Grade 1 oblique strains can sideline players for upwards of a month. Of course, every injury is different, and there are certainly instances of players returning far sooner than that. The Mets figure to have a formal announcement on Scherzer’s status at some point today.

8:00am: Mets ace Max Scherzer pulled himself from last night’s game midway through a sixth-inning at-bat against Albert Pujols (video link). After throwing a 2-2 slider to Pujols, Scherzer immediately motioned to the dugout that he was done, calling for a trainer and promptly exiting the game. The Mets announced that Scherzer was dealing with discomfort in his left side, and Scherzer told reporters after the contest that he’d felt tightness in his side throughout the day and felt a “zing” during the Pujols at-bat (video link). “I just knew I was done,” said Scherzer. The three-time Cy Young winner added that he doesn’t believe the injury to be a “major strain.”

That’ll be determined this morning, it seems, as MLB.com’s Anthony DiComo writes that Scherzer is headed for an MRI to determine the extent of the injury. While Scherzer himself downplayed the potential severity, it’s obviously a point of concern that he both pulled himself from the game and is now undergoing a round of imaging to determine whether a trip to the injured list will be necessary.

The 37-year-old right-hander inked a record-setting three-year, $130MM contract with the Mets over the winter, making him the highest paid player (on an annual basis) in Major League history. Thus far, Scherzer has been the co-ace the Mets hoped to be acquiring when doling out that deal, pitching 49 2/3 innings of 2.54 ERA ball with a 30.6% strikeout rate against a 5.7% walk rate. He’s been a major reason that the Mets’ rotation, even without Jacob deGrom, ranks fifth in the Majors in ERA and second in FIP. Scherzer and his rotation-mates have also combined for the seventh-highest strikeout rate and the lowest walk rate of any starting staff in the big leagues.

At present, the Mets are the only team in the NL East with a winning record, and at 25-14 they hold a healthy six-game lead over the second-place Phillies. That said, even a brief absence for Scherzer, placing him on the shelf alongside deGrom and righty Tylor Megill (biceps inflammation), would be a notable blow. The Mets do have a deep staff that could potentially weather that trio of rotation injuries in the short-term, with lefty David Peterson presumably serving as the next man in line if Scherzer indeed misses time. Still, losing their $76.83MM one-two deGrom/Scherzer punch to the injured list before the pair is ever even healthy enough to take the mound on consecutive days isn’t a scenario the Mets hoped to face.

The Mets announced earlier this week that an MRI on deGrom, who has yet to pitch in 2022 due to a stress reaction in his right scapula, showed “continued healing.” He’s working through a throwing program and currently building up the distance from which he throws and the intensity level, but there’s no clear timetable for him to get back onto the mound and embark on a minor league rehab assignment. If Scherzer were to join deGrom and Megill on the IL, the Mets’ rotation would likely consist of Chris Bassitt, Carlos Carrasco, Taijuan Walker, Trevor Williams and the aforementioned Peterson.

Royals Select Dairon Blanco

The Royals announced Thursday that they’ve selected the contract of outfielder Dairon Blanco from Triple-A Omaha and placed outfielder Michael A. Taylor on the injured list. Royals skipper Mike Matheny told reporters last night that Taylor was in contact tracing under the league’s health-and-safety protocols, though it’s not clear yet whether he’s tested positive. Regardless, it’ll be Blanco assuming his spot on the roster at least in the short term. Kyle Isbel is in center for the Royals’ series finale against the White Sox today.

The 29-year-old Blanco will be making his big league debut if he gets into a game. Originally signed out of Cuba by the Athletics back in 2017, Blanco was one of two players the Royals received when trading lefty Jake Diekman to Oakland back in 2019. He had a rough go of it in Double-A following that trade, but Blanco has posted solid minor league numbers in 2021 (.277/.350/.441) and so far in 2022 (.263/.381/.442) between the Double-A and Triple-A levels.

Blanco swiped 41 bases in 55 tries last year, and he’s out to a 13-for-13 start in that department so far in 2022. At 29 years of age, he’s older than your standard “prospect,” though he still got a brief mention on FanGraphs’ 2021 rankings, where Eric Longenhagen credited him with 80-grade speed (on the 20-80 scale) and praised his strong exit velocities at the plate. He’s played center field and left field extensively with the Royals but has just one appearance in right.

It should be noted that the Royals did not specify Blanco as a Covid-related “substitute” or “replacement” when announcing they’d selected his contract. Each team’s wording tends to vary a bit on transactions of this nature, but they all typically make specific mention when someone is a pure substitute player. Those players can be sent back to the minor leagues without first passing through waivers. However, the Royals stating that Blanco’s contract has been formally selected ostensibly signals that there’s some permanence behind the move. Assuming Blanco is on the 40-man roster to stay, he’ll give the Royals some additional, optionable outfield depth for the foreseeable future.

As for Taylor, his placement on the Covid list could be due to a positive test, symptoms or continued contact tracing. If he did test positive, health protocols technically call for a 10-day absence, although players can return sooner than that with a pair of negative tests and approval from a joint MLB/MLBPA panel (one appointed medical expert from each party). In 117 plate appearances this season, Taylor is hitting .238/.333/.337 with strong marks in Defensive Runs Saved and Outs Above Average.